Protagenic Therapeutics Inc (PTIX)
1.23
-0.02
(-1.60%)
USD |
NASDAQ |
May 07, 16:00
1.26
+0.03
(+2.44%)
After-Hours: 20:00
Protagenic Therapeutics Cash from Investing (TTM): 4.776M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 4.776M |
September 30, 2023 | 2.659M |
June 30, 2023 | 2.426M |
March 31, 2023 | 1.521M |
December 31, 2022 | 1.597M |
September 30, 2022 | 1.921M |
June 30, 2022 | -8.832M |
March 31, 2022 | -9.539M |
December 31, 2021 | -9.910M |
September 30, 2021 | -10.40M |
June 30, 2021 | 0.00 |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 0.25M |
September 30, 2019 | 0.4955M |
June 30, 2019 | 0.853M |
March 31, 2019 | 1.090M |
December 31, 2018 | 1.046M |
September 30, 2018 | 0.6665M |
June 30, 2018 | 0.9854M |
March 31, 2018 | -1.081M |
December 31, 2017 | -1.286M |
Date | Value |
---|---|
September 30, 2017 | -1.153M |
June 30, 2017 | -1.829M |
March 31, 2017 | 0.00 |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 0.00 |
June 30, 2014 | -0.001M |
March 31, 2014 | -0.221M |
December 31, 2013 | -0.27M |
September 30, 2013 | -0.912M |
September 30, 2011 | -0.551M |
June 30, 2011 | 0.026M |
March 31, 2011 | 0.066M |
December 31, 2010 | 0.679M |
September 30, 2010 | 0.312M |
June 30, 2010 | -1.354M |
March 31, 2010 | -1.14M |
December 31, 2009 | 2.366M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-10.40M
Minimum
Sep 2021
4.776M
Maximum
Dec 2023
-1.584M
Average
0.6743M
Median
Cash from Investing (TTM) Benchmarks
Ekso Bionics Holdings Inc | -0.123M |
Eyenovia Inc | -3.970M |
Palisade Bio Inc | -- |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |